INS and rhabdomyosarcoma: In the rhabdomyosarcoma cell line Kym-1, an insulin receptor kinase inhibitor abolished the insulin-induced STAT5 tyrosine phosphorylation, but this effect was not obtained with a JAK2 kinase inhibitor [29].